Anzor Pharmaceuticals to Present at Chronic Kidney Disease Conference
FGF TECHNOLOGY REPRESENTS MAJOR BREAKTHROUGH IN METABOLIC AND CANCER DISEASES BOSTON, March 19, 2025 – Anzor Pharmaceuticals, a leader in the development of targeted fibroblast growth factor (FGF) peptide therapy, today announced that Christopher P Adams, CEO will present at the 7th Annual Chronic Kidney Disease Conference in Boston Massachusetts on March 19, 2025. […]
